Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2020-10-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
独立董事关于第二届董事会第十一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding matters discussed at the company's second board meeting, specifically about the completion of a fundraising investment project and the permanent allocation of surplus funds to working capital. It references compliance with regulatory guidelines and company bylaws, and it is signed by independent directors. The content focuses on board-level decisions and opinions rather than financial results, audit findings, or shareholder voting outcomes. It is not a full annual or interim report, nor is it a voting result announcement. The document fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent director opinions on company governance and fund usage.
2020-10-29 Chinese
第二届监事会第八次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the eighth meeting of the second Supervisory Board of Zhejiang Tailin Biotechnology Co., Ltd. It includes the approval of the company's 2020 third quarter report and a proposal regarding the use of surplus raised funds. The document references the full 2020 third quarter report being published on an external website and does not contain the actual financial statements or detailed financial data itself. The document is relatively short (1442 characters) and serves as a formal announcement of meeting decisions and approvals rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not meet the criteria for an Interim/Quarterly Report (IR) or other specific report types.
2020-10-29 Chinese
关于2020年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (351 characters) stating that the company's 2020 third quarter report has been disclosed on an official website. It does not contain the actual financial data or substantive analysis but merely informs investors to check the report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about the report's availability is classified as a Report Publication Announcement (RPA), not the report itself.
2020-10-29 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed information disclosure management system of Zhejiang Tailin Biotechnology Co., Ltd., outlining principles, rules, and procedures for information disclosure, including definitions of periodic reports (annual, semi-annual, quarterly), temporary reports, disclosure of major events, board and shareholder meeting procedures, and related party transactions. It references regulatory frameworks such as the Company Law, Securities Law, and Shenzhen Stock Exchange rules. The content is a governance and compliance manual rather than an actual report or announcement. It does not contain financial statements, earnings data, or voting results. It is a governance-related document detailing internal rules and disclosure practices.
2020-10-29 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Shareholders' Meeting Rules" of Zhejiang Tailin Biotechnology Co., Ltd. It extensively details the procedures, rules, and regulations governing the conduct of shareholders' meetings, including the convening, proposal submission, voting, and record-keeping processes. There is no financial data, earnings information, or report content. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings and corporate governance. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial and contains detailed governance rules, not just an announcement or summary, so it is not an RPA or RNS. Therefore, the correct classification is CGR with high confidence.
2020-10-29 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Zhejiang Tailin Bioengineering Co., Ltd. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, and other governance matters. It references relevant laws and regulations such as the Company Law of China, Securities Law, and listing rules. The content is a comprehensive governance document that sets out the internal rules and structure of the company rather than financial results, audit opinions, or meeting announcements. It is not a report of financial performance, nor an announcement or transcript. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance provisions, confirming it is the governance document itself, not an announcement or summary.
2020-10-29 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.